MRNA Mar 2023 115.000 call
| Previous close | 75.03 |
| Open | 57.85 |
| Bid | 59.60 |
| Ask | 61.60 |
| Strike | 115.00 |
| Expiry date | 2023-03-17 |
| Day's range | 57.85 - 57.85 |
| Contract range | N/A |
| Volume | |
| Open interest | 30 |
- Zacks
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Moderna (MRNA) closed at $174.30, marking a -1% move from the previous day.
- Motley Fool
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Novavax (NASDAQ: NVAX) has offered investors just such a ride over the past few years. Initial gains came as investors bet on Novavax's chances of bringing a coronavirus vaccine to market; declines occurred after the vaccine entered the market later than rival products did. Now, as we start a new year, you might be wondering what to do about Novavax.
- Motley Fool
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now
The bad news is Moderna's vaccine may not be able to replicate these levels in a post-pandemic environment. The good news is the vaccine still could lead to significant blockbuster revenue -- and that will support the development of Moderna's late-stage pipeline. As a result, Moderna could launch other potential blockbusters over the next few years.
